In our Stamford practice, we: Review your orthopedic and medical history Evaluate concurrent therapies (PRP, stem cells, surgery, physical therapy) Choose dosing schedules tailored to your goals Monitor progress, side effects, and outcomes We also avoid peptides in certain situations (e.g., active cancer, pregnancy, uncontrolled autoimmune flares) unless carefully coordinated with the rest of your care team

Professor Jastreboffs research contributions include: Principal investigator for GLP3 phase 2 obesity trial demonstrating 24.2% weight loss Leadership in clinical research examining triple hormone receptor agonists Extensive investigations of incretin-based therapies for obesity and metabolic disease Pioneering work on combination approaches to weight management Studies examining neurobiological mechanisms underlying obesity pharmacotherapy Her work has helped establish GLP3 as one of the most promising next-generation obesity treatments in clinical development, contributing to the scientific foundation for multi-pathway metabolic interventions
What this protocol cannot promise No published human trial measures GLOW outcomes
CJC-1295 / Ipamorelin : Boosts growth hormone and IGF-1 for vitality, weight loss, and increased vitality